- Home
- BBOT vs FBYD Comparison
BBOT vs FBYD Comparison
Compare BBOT & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBOT | FBYD |
|---|---|---|
| Founded | 2016 | 2021 |
| Country | United States | United States |
| Employees | N/A | 243 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.6M | 360.1M |
| IPO Year | 2024 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BBOT | FBYD |
|---|---|---|
| Price | $3.95 | $8.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $24.00 | N/A |
| AVG Volume (30 Days) | ★ 658.7K | 122.9K |
| Earning Date | 05-26-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.93 | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $14,896,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $209.00 |
| Revenue Growth | N/A | ★ 120.85 |
| 52 Week Low | $3.79 | $3.71 |
| 52 Week High | $14.87 | $29.02 |
Technical Indicators
Market Signals| Indicator | BBOT | FBYD |
|---|---|---|
| Relative Strength Index (RSI) | 18.86 | 51.93 |
| Support Level | N/A | $6.01 |
| Resistance Level | $9.53 | $8.87 |
| Average True Range (ATR) | 0.37 | 0.72 |
| MACD | -0.10 | 0.28 |
| Stochastic Oscillator | 5.34 | 92.15 |
Price Performance
Historical ComparisonAbout BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc is a visionary entertainment and technology enterprise. The group designs, develops, engineers, delivers, and commercializes immersive physical and digital experiences for brands, developers, and destination operators world-wide, as well as for its own portfolio of entertainment and technology concepts. The Company has five operating segments: Falcon's Creative Group, Destinations Operations, PDP, Falcon's Beyond Brands, and Falcon's Attractions. It earns the majority of the revenue from Falcon's Creative Group segment.